Outcome in medullary thyroid carcinoma;Langzeitverlauf des medullaren Schilddrusenkarzinomes

Swiss Surgery

Volumn 2, Issue 5, 1996, Pages 181-186

  Wagner, H E ^a,c   Ruchti, Ch ^b   Studer, M ^a   Haldemann, A R ^a   Kinser, J ^a   Burgi U ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c Chirurgische Klinik Stadtspital Waid   (Switzerland)

Author keywords

medullary carcinoma of the thyroid; thyroid cancer

Indexed keywords

ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; FOLLOW UP; HUMAN; METASTASIS; PROGNOSIS; THYROID CARCINOMA; TREATMENT OUTCOME; ADULT; AGED; FEMALE; MALE; MEDULLARY CARCINOMA; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY; SIPPLE SYNDROME; SURVIVAL; THYROID TUMOR;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, MEDULLARY; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 0029681098     PISSN: 10239332     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Chabloz R, Bischoff T, Saraga P, Loosli H, Scazziga B, Burckhardt P, Saegesser F. Les carcinomes médullaires de la thyroide. Schweiz, med. Wschr 1983; 113:814-823.
2. Langer HJ, Leicht E, Biro G, Koch B, Berberich R, Weinges KF. Das C-Zell-Karzinom. Dt. Ärztebl. 1992; 89:28-32.
3. Nelkin BD, de Butros AC, Mabry M, Baylin SB. The molecular biology of medullary thyroid carcinoma. A model for cancer development and progression. JAMA 1989; 261:3130-3135.
4. Deftos LJ, Stein MF. Radioiodine as an adjunct to the surgical treatment of medullary thyroid carcinoma. J Clin Endocrinol Metabol 1980; 50:967-972.
5. Kujat C, Müller-Leisse C, Falk S, Adam W, Pfannenstiel P. Diagnostik des medullären Schilddrüsenkarzinoms. Dtsch. med. Wschr 1990; 115:1475-1479.
6. Lynn J, Gamvros OJ, Taylor S. Medullary carcinoma of the thyroid. World J Surg 1981; 5:27-32.
7. Simpson WJ, Palmer JA, Rosen IB, Mustard RA. Management of medullary carcinoma of the thyroid. Am J Surg 1982; 144:420-422.
8. Grauer A, Raue F, Gagel RF. Changing concepts in the management of hereditary and sporadic medullary thyroid carcinoma. Endocrinol Metabol Clin N Am 1990; 19:613-633.
9. Raue F, Geiger S, Buhr H, Frank-Raue K, Ziegler R. Prognostische Bedeutung des Calcitonin-Screenings beim familiären medullären Schilddrüsenkarzinom. Dtsch med Wschr 1993; 118:49-52.
10. UICC: International Union against Cancer. TNM Classification of malignant tumours, 4th, fully revised edition, ed. by Hermanek and L H. Sobin. Berlin: Springer-Verlag, 1988.
11. WHO. International histological classification of tumours, ed. by C.H.R Hedinger in collaboration with E.D. Williams and L.H. Sobin. Berlin: Springer-Verlag, 1988.
12. Saad MF, Ordonez NG, Rashid RK, Guido JJ, Hill Jr CS, Hickey RC, Samaan NA. Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients. Medicine 1984; 63:319-342.
13. Uribe M, Fenoglio PC, Grimes M, Feind C. Medullary carcinoma of the thyroid gland. Clinical, pathological, and immunohistochemical features with review of the literature. Am J Surg Pathol 1985; 9:577-594.
14. Schröder S, Böcker W, Baisch H, Bürk CG, Arps H, Meiners I, Kastendieck H, Heitz PU, Klöppel G. Prognostic factors in medullary thyroid carcinomas. Cancer 1988; 61:806-816.
15. Raue F, Winter J, Frank RK, Lorenz C, Ziegler R. Diagnostic procedure before reoperation in patients with medullary thyroid carcinoma. Horm Metabol Res Suppl 1989; 21:31-34.
16. Palmer BV. Calcitonin and carcino-embryonic antigen in the follow-up of patients with medullary carcinoma of the thyroid. Br J Surg 1984; 71:101-104.
17. Mendelsohn G, Wells SJ, Baylin SB. Relationship of tissue carcinoembryonic antigen and calcitonin to tumor virulence in medullary thyroid carcinoma. An immunohistochemical study in early, localized, and virulent disseminated stages of disease. Cancer 1984; 54:657-662.
18. Gorman B, Charboneau JW, James EM et al. Medullary thyroid carcinoma: Role of high-resolution U.S. Radiology 1987; 162:147.
19. Als C, Listewnik M, Ritter EP, Kinser J, Rösler H. Quantitative substraction scintigraphy with 99m Tc-MIBI in cold thyroid nodules. Eur J Nucl Med 1993; 20.
20. Krenning EP, Bakker WH, Breemann WAP et al. Localization of endocrine-related tumors with radioiodinated analogue of somatostatin. Lancet 1989; 1:242-244.
21. Krenning EP, Kwekkeboom DJ, Bakker WH et al. Somatostatin receptor scintigraphy with (111 In-DTPA-D-Phe1)- and (123I-Tyr3)-octreotide: The Rotterdam experience with more than 1000 pa tients. Eur J Nucl Med 1993; 76:716-731.
22. Kwekkeboom DJ, Reubi JC, Lamberts SWJ et al. In vivo somatostatin receptor imaging in medullary thyroid carcinoma. J Clin Endocrinol Metabol 1993; 76:1413-1417.
23. Dörr U, Frank-Raue K, Grauer A, Hehrmann R, Buhr HJ, Raue F, Bihl H. Somatostatin und medulläres Schilddrüsenkarzinom: Diagnostische und therapeutische Überlegungen. Der Nuklearmediziner 1993; 16:331-340.
24. Reubi JC. Clinical relevance of somatostatin receptor imaging. Eur J Endocrinol 1994; 131:576-578.
25. Norton JA, Doppman JL, Brennan MF. Localization and resection of clinically inapparent medullary carcinoma of the thyroid. Surgery 1980; 87:616-621.
26. Raue F, Kotzerke J, Reinwein D et al. Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German medullary carcinoma register. Clin Invest 1993; 71:7-12.
27. Kallinowski F, Buhr HJ, Meybier H, Eberhardt M, Herfarth C. Medullary carcinoma of the thyroid - therapeutic strategy derived from fifteen years of experience. Surgery 1993; 114:491-496.
28. Byers RM. Modified neck dissection. Am J Surg 1985; 150:414-421.
29. Jackson CE, Talpos GB, Kambouris A, Yott JB, Tashjian Jr. AH, Block MA. The clinical course after definitive operation for medullary thyroid carcinoma. Surgery 1983; 94:995-1001.
30. Tisell LE, Hansson G, Jansson S, Salander H. Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma. Surgery 1986; 99:60-66.
31. Buhr HJ, Kallinowski F, Raue F, Frank-Raue K, Herfarth C. Microsurgical neck dissection for occultly metastasizing medullary thyroid carcinoma. Cancer 1993; 72:3685-3693.
32. Jensen MH, Davis RK, Derrick L. Thyroid cancer: a computer-assisted review of 5287 cases. Otolaryngol Head Neck Surg 1990; 102:51-55.